I call what Dew and others are doing the "Christopher Columbus Syndrome" having seen it all too many times. This syndrome in effect says that things can not go well, nor can new ideas be discovered because things have never gone well before and new things are rarely discovered. In effect we have never had a drug that works like Bavi so Bavi can not work.
As far as CRs are concerned: Let us be assured that those patients and their families still alive in the Bavi arms are quite satisfied whatever the technical classification of their condition.
Lastly here is a similar situation for those of you here who invest in NAVB I remind you of the results for RigScan where the immediate results were not overwhelming but after a period of years the survival rates were so much better that the EMEA requested NAVB to resurrect the drug. In some cases it just takes longer for the truth/facts to will out.
Looks like biotech sector is getting crapped on by QEIII. All the money is flowing to those companies likely to benefit from that event. Might keep sector weak or a while now.
News 
Market Data 
Discover 
AI
